| Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
| New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
| 58.com (WUBA) | Morgan Stanley/ Credit Suisse/ Citigroup | $150.00 | n.a. | |||
| Apparel Holding (VNCE) | Goldman Sachs/ Baird | $200.00 | n.a. | |||
| Biocept (BIOC ) | Aegis Capital | $23.00 | n.a. | |||
| CatchMark Timber Trust (CTT) | Raymond James | $172.50 | n.a. | |||
| Chrysler Group (tba) | J.P. Morgan | $100.00 | n.a. | |||
| Devon Midstream Partners, L.P. (DVNM) | BofA Merrill Lynch/ Barclays | $400.00 | n.a. | |||
| Evogene Ltd. (EVGN) | Credit Suisse/ Deutsche Bank Securities | $60.00 | n.a. | |||
| Marcus & Millichap (MMI) | Citigroup/ Goldman Sachs | $103.50 | n.a. | |||
| Relypsa (tba) | Morgan Stanley/ BofA Merrill Lynch | $126.50 | n.a. | |||
| Southeastern Grocers (SEG) | Citigroup/ Credit Suisse/ Deutsche Bank Securities/ William Blair/ Wells Fargo Securities | $500.00 | n.a. | |||
| n.a. (not available) | ||||||
| Postponed | ||||||
| None | ||||||
| Withdrawn | ||||||
| None | ||||||
| New Terms | ||||||
| ADMA Biologics (tba) | Oppenheimer & Co. | 2.67 | $8.50 | $9.50 | $24.00 | n.a. |
| Brixmor Property Group (BRX) | BofA Merrill Lynch/ Citigroup/ J.P. Morgan/ Wells Fargo Securities/ Barclays/ Deutsche Bank Securities/ RBC Capital Markets/ UBS Investment Bank | $100.00 | n.a. | |||
| Cherry Hill Mortgage Investment (CHMI) | Barclays/ Morgan Stanley/ Citigroup/ UBS Investment Bank | 6.50 | $20.00 | $20.00 | $130.00 | n.a. |
| Energy & Exploration Partners (ENXP) | Citigroup | $270.00 | n.a. | |||
| OCI Partners LP. (OCIP) | BofA Merrill Lynch/ Barclays/ Citigroup | 17.50 | $19.00 | $21.00 | $350.00 | n.a. |
| Ophthotech (OPHT) | Morgan Stanley/ J.P. Morgan | 7.60 | $19.00 | $20.00 | $148.20 | 3-Stars |
| Plains GP Holdings, L.P. (PAGP) | Barclays/ Goldman Sachs/ J.P. Morgan/ BofA Merrill Lynch/ Citigroup/ UBS Investment Bank/ Wells Fargo Securities | $1,000.00 | n.a. | |||
| Potbelly Corporation (PBPB) | BofA Merrill Lynch/ Goldman, Sachs | 7.50 | $9.00 | $11.00 | $75.00 | 3-Stars |
| QTS Realty Trust (QTS) | Goldman, Sachs/ Jefferies | 12.50 | $27.00 | $30.00 | $356.25 | n.a. |
| SFX Entertainment (SFXE) | UBS Investment Bank/ Jefferies/ Deutsche Bank Securitie | 16.67 | $11.00 | $13.00 | $200.00 | n.a. |
| Western Refining Logistics, LP (WNRL) | BofA Merrill Lynch/ Barclays/ Goldman Sachs/ Wells Fargo Securities | $287.50 | n.a. | |||
| n.a. (not available) | ||||||
| tba (to be announced) | ||||||
| IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
| Week of Sept. 23, 2013 | Manager(s) | Offered | Raised | Price | 9/27/13 | Change |
| Foundation Medicine (FMI) | Goldman, Sachs/ J.P. Morgan | 5.89 | $106.00 | $18.00 | $35.65 | 98.06% |
| Montage Technology Group (MONT) | Deutsche Bank Securities/ Barclays/ Stifel | 7.10 | $71.00 | $10.00 | $15.15 | 51.50% |
| RingCentral (RNG) | Goldman, Sachs/ J.P. Morgan/ BofA Merrill Lynch | 7.50 | $97.50 | $13.00 | $18.20 | 40.00% |
| Ophthotech (OPHT) | Morgan Stanley/ J.P. Morgan | 7.60 | $167.20 | $22.00 | $29.18 | 32.64% |
| Enzymotec (ENZY) | BofA Merrill Lynch/ Jefferies | 4.41 | $61.77 | $14.00 | $18.16 | 29.71% |
| Covisint (COVS) | Credit Suisse/ Pacific Crest Securities | 6.40 | $64.00 | $10.00 | $12.63 | 26.30% |
| Premier (PINC) | J.P. Morgan/ BofA Merrill Lynch/ Wells Fargo Securities | 28.15 | $760.10 | $27.00 | $31.69 | 17.37% |
| Pattern Energy Group (PEGI) | BMO Capital Markets/ RBC Capital Markets/ Morgan Stanley | 16.00 | $352.00 | $22.00 | $23.27 | 5.77% |
| Applied Optoelectronics (AAOI) | Raymond James/ Piper Jaffray | 3.60 | $36.00 | $10.00 | $10.10 | 1.00% |
| Evoke Pharma (EVOK) | Aegis Capital Corp. | 2.10 | $25.20 | $12.00 | $12.03 | 0.25% |
| Capitala Finance (CPTA) | Deutsche Bank Securities/ UBS Investment Bank/ Barclays | 4.00 | $80.00 | $20.00 | $19.05 | -4.75% |
| Violin Memory (VMEM) | J.P. Morgan/ Deutsche Bank Securities/ BofA Merrill Lynch | 18.00 | $162.00 | $9.00 | $7.02 | -22.00% |
